Deal Watch: Seagen Ups Presence In HER2-Positive Cancer Field With RemeGen Deal

 
• By Joseph Haas, Vibha Ravi, and Mandy Jackson

Lilly partners with Kumquat to discover small molecule IO drug. Kite, Appia Bio collaborate on allogeneic cell therapies. AstraZeneca and Regeneron pursue novel metabolic therapies targeting GPR75. Lexeo and Stelios merge to focus on gene therapies for rare cardiovascular indications.

Deal Watch 2021

More from Deals

More from Business